TOPPLE T1D A multiple ascending dose trial investigating safety, tolerability and pharmacokinetics of NNC0361-0041 administered subcutaneously to patients with type 1 diabetes mellitus
If you are interested in this clinical trial, please contact Michelle Murphy on the Children’s Health Research Team.Call 972-754-4794Email
STU-2021-0175
NCT04279613
topple t1d,diabetes,tn27
TOPPLE T1D A multiple ascending dose trial investigating safety, tolerability and pharmacokinetics of NNC0361-0041 administered subcutaneously to patients with type 1 diabetes mellitus
